Boston Scientific appoints Joseph Fitzgerald chief operating officer
BSX•Boston Scientific appointed Joseph M. Fitzgerald executive vice president and chief operating officer. The company will establish three reportable segments effective Jan. 1, 2027: Interventional Therapies, Rhythm Solutions and MedSurg.
1. Leadership and segments
Boston Scientific appointed Joseph M. Fitzgerald executive vice president and chief operating officer. Effective Jan. 1, 2027, the company will establish three reportable segments: Interventional Therapies, Rhythm Solutions and MedSurg.
